Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

ETS Transcription Factor Etsrp/Etv2 Is Required for Lymphangiogenesis in Zebrafish and Is a Potential Therapeutic Target in Lymphatic Disease

Jennifer A. Davis, DO, Sharina Palencia Desai, PhD, Saulius Sumanas, PhD

Blood (2014) 124 (21): 2767.

https://doi.org/10.1182/blood.V124.21.2767.2767

Published: 2014

Journal Articles

Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))

Klaus Herfarth, MD, Marianne Engelhard, MD, Peter Borchmann, MD, Karin Hohloch, MD, Volker Budach, MD, Andreas Viardot, MD, Mathias Witzens-Harig, MD, Hans Eich, MD, Wolfgang Hiddemann, MD, PhD, Martin Dreyling

Blood (2012) 120 (21): 1634.

https://doi.org/10.1182/blood.V120.21.1634.1634

Published: 2012

Journal Articles

Comprehensive Cytogenetic and Molecular Genetic Characterization of T-PLL Identifies for the First Time BCOR Mutations in a Lymphatic Disease.

Vera Grossmann, MSc, Alexander Kohlmann, PhD, María Abáigar, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD, Claudia Haferlach, MD

Blood (2012) 120 (21): 2539.

https://doi.org/10.1182/blood.V120.21.2539.2539

Published: 2012

Journal Articles

Investigation of ETV2/Etsrp Role in Lymphangiogenesis: A Potential Therapeutic Target in Lymphatic Disease

Jennifer D. Williams, DO, Sharina Palencia Desai, MA, Saulius Sumanas, PhD

Blood (2012) 120 (21): 614.

https://doi.org/10.1182/blood.V120.21.614.614

Published: 2012

Journal Articles

Long-Term Survival and Quality of Life Assessment After Allogeneic Stem-Cell Transplantation; Comparable Results Following Myeloablative and Reduced-Intensity Conditioning,

Avichai Shimoni, MD, Eran Tallis, MD, Noga Shem-Tov, MD, Yulia Volchek, MD, Ronit Yerushalmi, MD, Arnon Nagler

Blood (2011) 118 (21): 4096.

https://doi.org/10.1182/blood.V118.21.4096.4096

Published: 2011

Journal Articles

Hematopoietic Stem Cells Contribute to Lymphatic Endothelium.

Shuguang Jiang, Alexis S. Bailey, John R. Swain, Erin M. Hewett, Melissa H. Wong, Philip R. Streeter, William H. Fleming

Blood (2006) 108 (11): 1658.

https://doi.org/10.1182/blood.V108.11.1658.1658

Published: 2006

NARROW

ETS Transcription Factor Etsrp/Etv2 Is Required for Lymphangiogenesis in Zebrafish and Is a Potential Therapeutic Target in Lymphatic Disease

Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))

Comprehensive Cytogenetic and Molecular Genetic Characterization of T-PLL Identifies for the First Time BCOR Mutations in a Lymphatic Disease.

Investigation of ETV2/Etsrp Role in Lymphangiogenesis: A Potential Therapeutic Target in Lymphatic Disease

Long-Term Survival and Quality of Life Assessment After Allogeneic Stem-Cell Transplantation; Comparable Results Following Myeloablative and Reduced-Intensity Conditioning,

Hematopoietic Stem Cells Contribute to Lymphatic Endothelium.

Email alerts

ASH Publications

American Society of Hematology

ETS Transcription Factor Etsrp/Etv2 Is Required for Lymphangiogenesis in Zebrafish and Is a Potential Therapeutic Target in Lymphatic Disease

Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))

Comprehensive Cytogenetic and Molecular Genetic Characterization of T-PLL Identifies for the First Time BCOR Mutations in a Lymphatic Disease.

Investigation of ETV2/Etsrp Role in Lymphangiogenesis: A Potential Therapeutic Target in Lymphatic Disease

Long-Term Survival and Quality of Life Assessment After Allogeneic Stem-Cell Transplantation; Comparable Results Following Myeloablative and Reduced-Intensity Conditioning,

Hematopoietic Stem Cells Contribute to Lymphatic Endothelium.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only